Educational, research-use-only content. This article summarizes published scientific literature for informational purposes only and is not medical advice. The compounds discussed are supplied strictly for in-vitro laboratory research and are not approved for human or veterinary use.
What is Sermorelin?
Sermorelin is a synthetic analog of growth-hormone-releasing hormone (GHRH). It belongs to a family of GHRH analogs — alongside tesamorelin and CJC-1295 — that are studied in the context of the growth-hormone axis (Memdouh et al., 2021)., 2021). This kind of metabolism and detection work is a significant part of the published literature on these compounds.
Regulatory status and limits
- GHRH and its analogs are prohibited by the World Anti-Doping Agency; sermorelin is not approved for anti-aging or performance use.
- It is supplied here strictly for laboratory research use only and has not been approved by the U.S. Food and Drug Administration for such uses.
References
According to PubMed:
- Memdouh S, et al. Advances in the detection of growth hormone releasing hormone synthetic analogs. Drug Test Anal. 2021. doi:10.1002/dta.3183
Disclaimer: This content is provided for educational and informational purposes only and reflects published preclinical and laboratory research. It is not medical advice and makes no claim regarding the diagnosis, treatment, cure, or prevention of any disease. Products referenced are intended solely for in-vitro laboratory research use only (RUO); they are not for human or veterinary use, consumption, or application, and have not been approved by the U.S. Food and Drug Administration.
